Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders
Part of paid clinical trials in The Woodlands, Texas.
- Sponsor
- Healing Hope International
- Study ID
- NCT07493096
- Status
- Recruiting
Conditions
- 22q11.2 Deletion Syndrome
- Autism Spectrum Disorder
- Autism Spectrum Disorder (ASD
- Cerebral Palsy (CP)
- Cerebral Palsy Hemiparetic Cerebral Palsy Spasticity Gait Disorders, Neurologic Postural Balance Impairment
- Cerebral Palsy Infantile
- Cerebral Palsy Spastic Hemiplegic
- Cerebral Palsy, Dyskinetic
- Chromosomal Abnormalities
- Developmental Delay (Disorder)
- Down Syndrome (Trisomy 21)
- Fragile X Syndrome (FXS)
- Genetic Disorders
- Hypoxic Ischemic Encephalopathy
- Hypoxic Ischemic Encephalopathy (HIE)
- Neurodevelopmental Disorders
- Neurodevelopmental Disorders (NDD)
- Neurodevelopmental Disorders and Developmental Abnormalities
- RETT Syndrome With Proven MECP2 Mutation
- Sensorimotor Integration
- Sensory Processing Disorder
- Traumatic Brain Injury (TBI)
- Williams Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 4 Years - 12 Years
- Healthy Volunteers
- Not accepted
Study Details
This observational study evaluates functional and developmental outcomes in pediatric participants undergoing a two week intensive multimodal neurorehabilitation program. The program is designed for children with neurodevelopmental disorders, including but not limited to cerebral palsy, autism spectrum disorder, developmental delay, hypoxic ischemic encephalopathy (HIE), and chromosomal or genetic abnormalities. Participants receive individualized therapy sessions for approximately 2.5 hours per day over a two week period. The intervention is not standardized but is tailored to each child's specific needs and may include components such as sensory integration, motor planning, reflex integration, oculomotor training, executive functioning activities, communication support, and other brain based therapeutic approaches. The purpose of this study is to observe changes in functional abilities, including attention, motor coordination, emotional regulation, communication, and activities of daily living. Outcomes are assessed using clinician observation and parent reported changes before and after the intensive program, with limited follow-up when available. This study does not assign participants to a specific treatment as part of a research protocol. Instead, it collects real world data from children already participating in a clinical therapy program to better understand potential benefits of intensive, individualized neurorehabilitation approaches.
Key Dates
- Start date
- Mar 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Jan 1, 2028
- Completion
- Dec 30, 2036
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Pediatric Intensive Multimodal Neurorehabilitation CohortThis cohort includes pediatric participants with neurodevelopmental disorders, including cerebral palsy, autism spectrum disorder, developmental delay, hypoxic ischemic encephalopathy, traumatic brain injury, and genetic or chromosomal abnormalities, who are enrolled in a two-week intensive multimodal neurorehabilitation program. Participants receive individualized therapy for approximately 2.5 hours per day, 5 days per week, for 2 consecutive weeks. The intervention is not standardized and is tailored to each participant's clinical needs. Therapy may include sensory integration, motor planning, reflex integration, oculomotor training, auditory processing activities, executive functioning tasks, communication support, emotional regulation strategies, and other neurodevelopmental approaches. Additional modalities such as tactile stimulation, vibration, and photobiomodulation may be utilized at the discretion of the treating clinician.
Primary Outcome Measure
Change in Clinician Assessed Functional Neurodevelopmental Performance [ Time Frame: Baseline to end of 2 week intensive program ]
Central Contacts
- Genelle Mills, OTR/L(480) 620-4514
- Tamara Tamas, MS RA(863) 354- 5131
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ability and Beyond | The Woodlands | Texas | 77380 |
Find similar trials in The Woodlands, TX
Related Studies
- Cerebellar tDCS in Children With Autism Spectrum DisorderRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Genetic Inclusion by Virtual EvaluationRecruiting · Baylor College of Medicine · Edinburg, Texas
- Rett Syndrome RegistryRecruiting · International Rett Syndrome Foundation · Birmingham, Alabama
- International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum DisorderRecruiting · Stalicla SA · Phoenix, Arizona